During the past decade, IPS-Universitaria conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "IPS-Universitaria" #1 sponsor was "Baxalta now part of Shire" with 2 trials, followed by "Grupo Rehabilitacion en Salud" with 2 trials sponsored, "Universidad de Antioquia" with 2 trials sponsored, "Arbor Pharmaceuticals, Inc." with 1 trials sponsored and "Centro de Excelencia en Enfermedades de Cabeza y Cuello" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "IPS-Universitaria" #1 collaborator was "Takeda Development Center Americas, Inc." with 2 trials as a collaborator, "Universidad de Antioquia" with 2 trials as a collaborator, "Grupo de Investigacion Dermatologica (GRID)" with 1 trials as a collaborator, "Grupo de via aerea dificil universidad de antioquia" with 1 trials as a collaborator and "IPS Universitaria-Universidad de Antioquia" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "IPS-Universitaria" are "Chronic Inflammatory Demyelinating Polyradiculoneuropathy" (2 trials), "Back Pain Lower Back" (1 trials), "Facial Photodamage" (1 trials), "Goiter" (1 trials) and "Hypertension" (1 trials). Many other conditions were trialed in "IPS-Universitaria" in a lesser frequency.

Most popular intervention types in "IPS-Universitaria" are "Drug" (5 trials), "Biological" (2 trials), "Other" (2 trials), "Behavioral" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "HYQVIA" (2 trials), "0.25% albumin placebo solution with rHuPH20" (1 trials), "Azilsartan Medoxomil High-dose" (1 trials), "Azilsartan Medoxomil Low-dose" (1 trials) and "Azilsartan Medoxomil Medium-dose" (1 trials). Other intervention names were less common.

The vast majority of trials in "IPS-Universitaria" are 9 trials for "All" genders.

Currently, there are NaN active trials in "IPS-Universitaria". 1 are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in IPS-Universitaria, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in IPS-Universitaria, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".